With a market cap of $121,1 billion, Gilead Sciences, Inc. (GILD) is a leading biopharmaceutical company specializing in the discovery, development, and commercialization of innovative medicines.

Gilead Sciences (GILD) is expected to deliver a year-over-year decline in earnings on lower revenues when it reports results for the quarter ended December 2024. This widely-known consensus ...

In this article, we are going to take a look at where Gilead Sciences, Inc. (NASDAQ:GILD) stands against other best wide moat stocks to invest in. Russell Investments continues to monitor and ...

Gilead Sciences has shored up its antibody-drug conjugate pipeline by licensing a candidate from German biotech Tubulis in a deal worth up to $415 million. The agreement includes an upfront ...

Gilead Sciences' TROP2-directed drug Trodelvy has missed the target in another clinical trial, this time in urothelial carcinoma, the most common form of bladder cancer. The results of the TROPiCS ...

TAMPA BAY, Fla. (BLOOM) – Love is in the air, and what better way to celebrate than with a sweet dining experience at The Sugar Factory inside the Hard Rock? Known for its playful atmosphere ...

One of Bury’s most recognised exports is to be showcased on an episode of BBC’s Inside The Factory. The Bury Black Pudding Company, which has a factory site in Heap Bridge and regularly sells ...

The final episode of the current run sees Paddy McGuinness visit a factory in Northern Ireland that churns out an incredible half a million sausage rolls every day. Plus, Ruth Goodman reveals the ...

Thank you for signing up! Did you know with an ad-lite subscription to Peterborough Telegraph, you get 70% fewer ads while viewing the news that matters to you. Police got more than they bargained ...